Literature DB >> 35235737

The Future of SARS-CoV-2 Vaccination.

Martin F Bachmann1, Mona O Mohsen1, Daniel E Speiser1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2022        PMID： 35235737     DOI： 10.1056/NEJMc2119437

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  3 in total

1.  Increased Receptor Affinity and Reduced Recognition by Specific Antibodies Contribute to Immune Escape of SARS-CoV-2 Variant Omicron.

Authors:  Anne-Cathrine S Vogt; Gilles Augusto; Byron Martina; Xinyue Chang; Gheyath Nasrallah; Daniel E Speiser; Monique Vogel; Martin F Bachmann; Mona O Mohsen
Journal:  Vaccines (Basel)       Date:  2022-05-09

2.  Virus-Like Particles Are Efficient Tools for Boosting mRNA-Induced Antibodies.

Authors:  Anne-Cathrine S Vogt; Lukas Jörg; Byron Martina; Pascal S Krenger; Xinyue Chang; Andris Zeltins; Monique Vogel; Mona O Mohsen; Martin F Bachmann
Journal:  Front Immunol       Date:  2022-06-16       Impact factor: 8.786

3.  Increased receptor affinity of SARS-CoV-2: a new immune escape mechanism.

Authors:  Martin F Bachmann; Mona O Mohsen; Daniel E Speiser
Journal:  NPJ Vaccines       Date:  2022-05-25       Impact factor: 9.399
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.